These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30684890)

  • 1. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
    Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
    Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.
    Lee LY; Köhler UA; Zhang L; Roenneburg D; Werner S; Johnson JA; Foley DP
    Toxicol Sci; 2014 Dec; 142(2):361-74. PubMed ID: 25294219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.
    Yang W; Liu L; Wei Y; Fang C; Liu S; Zhou F; Li Y; Zhao G; Guo Z; Luo Y; Li L
    Lab Invest; 2021 Mar; 101(3):369-380. PubMed ID: 33268842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
    Kim M; Yoo G; Randy A; Kim HS; Nho CW
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress.
    Zhang MH; Li J; Zhu XY; Zhang YQ; Ye ST; Leng YR; Yang T; Zhang H; Kong LY
    Free Radic Biol Med; 2021 Feb; 164():1-12. PubMed ID: 33388433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.
    Kang Y; Song Y; Luo Y; Song J; Li C; Yang S; Guo J; Yu J; Zhang X
    Free Radic Biol Med; 2022 Nov; 192():25-36. PubMed ID: 36096356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
    Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
    Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH.
    Zanieri F; Levi A; Montefusco D; Longato L; De Chiara F; Frenguelli L; Omenetti S; Andreola F; Luong TV; Massey V; Caballeria J; Fondevila C; Shanmugavelandy SS; Fox T; Mazza G; Argemi J; Bataller R; Cowart LA; Kester M; Pinzani M; Rombouts K
    Cells; 2020 May; 9(5):. PubMed ID: 32429478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease.
    Chen X; Sun X; Shen T; Chen Q; Chen S; Pang J; Mi J; Tang Y; You Y; Xu H; Ling W
    Free Radic Biol Med; 2020 Nov; 160():191-198. PubMed ID: 32810635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis.
    Park JS; Shim YJ; Kang BH; Lee WK; Min BH
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1775-1781. PubMed ID: 29229391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signaling.
    Xu Q; Fan Y; Loor JJ; Liang Y; Lv H; Sun X; Jia H; Xu C
    Food Funct; 2021 Jan; 12(2):696-705. PubMed ID: 33410857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin Attenuates Inflammation, Oxidative Stress, and DNA Damage in Mice with Nonalcoholic Steatohepatitis Induced by a Methionine- and Choline-Deficient Diet.
    Miguel FM; Picada JN; da Silva JB; Schemitt EG; Colares JR; Hartmann RM; Marroni CA; Marroni NP
    Inflammation; 2022 Oct; 45(5):1968-1984. PubMed ID: 35419738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
    Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
    Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomilin and its analogue obacunone alleviate NASH and hepatic fibrosis in mice via enhancing antioxidant and anti-inflammation capacity.
    Han Y; Luo L; Li H; Zhang L; Yan Y; Fang M; Yu J; Gao X; Liu Y; Huang C; Fan S
    Biofactors; 2023; 49(6):1189-1204. PubMed ID: 37401768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
    Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
    J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.